Preventive Therapy for Breast Cancer: A Consensus Statement
Preventive Therapy for Breast Cancer
J Cuzick, A DeCensi, B Arun, PH Brown, M Castiglione, B Dunn, JF Forbes, A Glaus, A Howell, G von Minckwitz, V Vogel, H Zwierzina
Yes
20110401
2011 May 1
Lancet Oncol
Preventive Therapy for Breast Cancer: A Consensus Statement
Lancet Oncol. 2011 May 1;12(5):496-503, J Cuzick, A DeCensi, B Arun, PH Brown, M Castiglione, B Dunn, JF Forbes, A Glaus, A Howell, G von Minckwitz, V Vogel, H Zwierzina
Abstract
Abstract
In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions. We present the conclusions in this Review. First we agreed that the term chemoprevention is inappropriate and suggested that the term preventive therapy better represents this feature of management. Two selective oestrogen-receptor modulators—tamoxifen and raloxifene—are so far the only medical options approved by the US Food and...
